[HTML][HTML] Coexistence of plasma cell neoplasia and myelodysplastic syndrome with excess blasts: case reports and literature review
W Yan, XY Qu, H Li, YC Li, Y Li, K Yao… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: The coexistence of plasma cell neoplasia such as multiple myeloma (MM) or
monoclonal gammopathy of underdetermined significance (MGUS) with myeloid neoplasia …
monoclonal gammopathy of underdetermined significance (MGUS) with myeloid neoplasia …
[HTML][HTML] Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series
Both clonal plasma cell and myeloid disorders occur more frequently with age. Patients with
concurrent clonal plasma cell and myeloid disorders (CPCMD) can present clinical and …
concurrent clonal plasma cell and myeloid disorders (CPCMD) can present clinical and …
[HTML][HTML] Co-occurrence of High-Risk Myelodysplastic Syndrome With a Complex Karyotype/TP53 Mutation and IgG Lambda Monoclonal Gammopathy of …
M Mir, W Aiman, E Baah, G Guron, H Shaaban - Cureus, 2024 - ncbi.nlm.nih.gov
Myelodysplastic syndrome (MDS) represents a group of hematologic disorders marked by
abnormal cellular development in the bone marrow, while monoclonal gammopathy of …
abnormal cellular development in the bone marrow, while monoclonal gammopathy of …
Identification of two independent clones underlying the co‐existence of myelodysplastic syndrome with excess of blasts type 2 and isolated 5q‐and smouldering …
M Quintini, S Arniani, S Ascani, C Camerini… - …, 2020 - Wiley Online Library
This report is dealing with simultaneous diagnosis of Myelodysplastic Syndrome with Excess
of Blasts 2 (MDS‐EB 2) with isolated 5q deletion and Smoldering Multiple Myeloma (SMM) …
of Blasts 2 (MDS‐EB 2) with isolated 5q deletion and Smoldering Multiple Myeloma (SMM) …
[HTML][HTML] Successful Treatment of Concurrently Diagnosed Multiple Myeloma and Myelodysplastic Syndrome With Isolated Del (5q) With Lenalidomide, Bortezomib …
NR Washington, EA Shippey, M Osswald - Cureus, 2021 - ncbi.nlm.nih.gov
Lenalidomide is known to be an effective therapy for multiple myeloma and for
myelodysplastic syndrome (MDS) with isolated del (5q). We report the case of a patient …
myelodysplastic syndrome (MDS) with isolated del (5q). We report the case of a patient …
[PDF][PDF] Współistnienie dyskrazji komórek plazmatycznych i zespołu mielodysplastycznego—opisy przypadków i przegląd piśmiennictwa
A Gołos, A Paczek, E Lech-Marańda, K Warzocha… - Hematologia, 2017 - core.ac.uk
Wprowadzenie do praktyki klinicznej nowych terapii wpłynęło na istotne wydłużenie
przeżycia chorych na szpiczaka plazmocytowego (PCM). Dłuższa obserwacja pacjentów …
przeżycia chorych na szpiczaka plazmocytowego (PCM). Dłuższa obserwacja pacjentów …
Coexistence of plasma cell dyscrasias and myelodysplastic syndrome—study of cases and review of literature
A Gołos, A Paczek, E Lech-Marańda… - … in Clinical Practice, 2017 - journals.viamedica.pl
The improvement in plasma cell myeloma (PCM) treatment and much longer overall survival
of the patients led to the observation of long-term complications of the therapy. These …
of the patients led to the observation of long-term complications of the therapy. These …